The FDA has issued a black-box warning for Veozah, a hot-flash medication, due to rare but serious liver risks Regular liver testing is recommended during Veozah treatment to ensure early ...

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

Veozah was approved in 2023. At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by blocking neurokinin B, a receptor involved in the ...

The FDA has issued a black-box warning for Veozah, a hot-flash medication, due to rare but serious liver risks Regular liver testing is recommended during Veozah treatment to ensure early detection of ...